aspect of
drug)
→
HasProperty
→
more frequent
| Typicality: | 0.303 |
| Saliency: | 0.330 |
| among those on invokana | 9 | location |
| in patients | 5 | location |
| with combination therapy | 3 | other |
| effect → be → more frequent | 16 |
| effect → be → more frequent among those | 5 |
| negative | neutral | positive |
| 0.509 | 0.454 | 0.037 |
| Raw frequency | 21 |
| Normalized frequency | 0.330 |
| Modifier score | 0.500 |
| Perplexity | 74.749 |